7 Dec 2018

Recent developments and highlights in biomarkers in allergic diseases and asthma

Drug hypersensitivity phenotypes excerpted from Fig. 5
Professor Robyn O'Hehir, Head of the Department of Respiratory Allergy & Clinical Immunology (Research) at Central Clinical School and Associate Professor Mark Hew, Head of Allergy, Asthma and Clinical Immunology at The Alfred are authors on a review article which explores the potential of precision medicine in allergy and asthma.

The authors, Eguiluz-Gracia et al., argue that there is a need to predict the response to specific therapies and the outcome of drug and food provocations. In their comprehensive review they have highlighted recent discoveries and advances in the identification and clinical applicability of valid biomarkers for asthma and allergic diseases.

View or download article: onlinelibrary.wiley.com/doi/full/10.1111/all.13628

No comments:

Post a Comment

Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.intranet@monash.edu.

Related Posts Plugin for WordPress, Blogger...